Opiorphin (OPI) antibody and antigen (hapten, BSA/OVA conjugated)

 Download 

Product information

Catalog No.	Description	US $ Price (per mg)
GMP-SMT-239-Ag01	BSA-Opiorphin (OPI)	756
GMP-SMT-239-Ag02	OVA-Opiorphin (OPI)	756
GMP-SMT-239-Ab01	Anti-human Opiorphin (OPI) mouse monoclonal antibody (mAb)	1953
GMP-SMT-239-Ab02	Anti-human Opiorphin (OPI) human monoclonal antibody (mAb)	1953

Size： 1mg | 10mg | 100mg

Product Description

Cat No. of Products	GMP-SMT-239-Ag01
Product Name	BSA-Opiorphin (OPI)
Target/Biomarker	Opiorphin (OPI)
Expression platform	Synthetic
Isotypes	NA
Bioactivity validation	Opiorphin (OPI) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in OPI level test of Pain () and related syndrome evaluation.
Tag	NA
Products description	Competitive immunoassay-validated hapten-carrier conjugates BSA-Opiorphin (OPI) / OVA-Opiorphin (OPI) is Synthetic.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products	GMP-SMT-239-Ag02
Product Name	OVA-Opiorphin (OPI)
Target/Biomarker	Opiorphin (OPI)
Expression platform	Synthetic
Isotypes	NA
Bioactivity validation	Opiorphin (OPI) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in OPI level test of Pain () and related syndrome evaluation.
Tag	NA
Products description	Competitive immunoassay-validated hapten-carrier conjugates BSA-Opiorphin (OPI) / OVA-Opiorphin (OPI) is Synthetic.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products	GMP-SMT-239-Ab01
Product Name	Anti-human Opiorphin (OPI) mouse monoclonal antibody (mAb)
Target/Biomarker	Opiorphin (OPI)
Expression platform	Hybridoma
Isotypes	Mouse IgG
Bioactivity validation	Opiorphin (OPI) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in OPI level test of Pain () and related syndrome evaluation.
Tag	mFc
Products description	Competitive immunoassay-validated hapten-carrier conjugates BSA-Opiorphin (OPI) / OVA-Opiorphin (OPI) is Synthetic.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products	GMP-SMT-239-Ab02
Product Name	Anti-human Opiorphin (OPI) human monoclonal antibody (mAb)
Target/Biomarker	Opiorphin (OPI)
Expression platform	Hybridoma
Isotypes	Mouse IgG
Bioactivity validation	Opiorphin (OPI) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in OPI level test of Pain () and related syndrome evaluation.
Tag	mFc
Products description	Competitive immunoassay-validated hapten-carrier conjugates BSA-Opiorphin (OPI) / OVA-Opiorphin (OPI) is Synthetic.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference

Validation Data

Click to get more Data / Case study about the product.

Target/Biomarker information

1. Opiorphin: A Comprehensive Overview and its Vital Role in In Vitro Diagnosis (IVD) Opiorphin is a remarkable small molecule with significant physiological importance, primarily serving as an endogenous inhibitor of enkephalin-degrading enzymes. Enkephalins, a class of natural peptides within the body, play pivotal roles in pain modulation and mood regulation. Opiorphin, through its function as an inhibitor, actively contributes to natural pain relief and mood enhancement. In the realm of in vitro diagnosis (IVD), Opiorphin takes on a distinctive role. Our esteemed biopharmaceutical company specializes in providing a wide array of resources, including anti-Opiorphin antibodies and a comprehensive suite of small molecule competitive antigens. This extensive range encompasses Carrier-coupled antigens, immunogens, hapten-carrier conjugates, BSA-conjugated, and OVA-conjugated forms, meticulously engineered to support the development of diagnostic assays tailored for the precise measurement and detection of Opiorphin levels within diverse biological samples, such as blood or urine. 2. The Significance of Opiorphin Measurement in IVD The measurement of Opiorphin holds paramount importance for several compelling reasons, each with its own unique implications: a. Pain Modulation and Management: Opiorphin's central role in natural pain relief mechanisms positions it as a key molecule in the field of pain management. Accurate measurement of Opiorphin levels is essential for gaining a deeper understanding of pain modulation and its intricacies. This, in turn, enables healthcare professionals and researchers to develop more targeted and effective pain management strategies. Opiorphin measurement can also aid in assessing the effectiveness of existing pain therapies. b. Mood Regulation and Mental Health: Opiorphin's involvement in mood enhancement introduces fascinating prospects for scientific exploration. Accurate measurement of Opiorphin levels may provide valuable insights into mood-related conditions such as depression and anxiety. This could pave the way for the development of innovative diagnostic tools for mood disorders and potentially lead to the discovery of novel therapeutic interventions. c. Biomarker Potential: Opiorphin has shown promise as a potential biomarker for various medical conditions, including pain-related disorders and mood disorders. Measuring Opiorphin levels has the potential to facilitate early diagnosis, disease monitoring, and the identification of individuals at risk of developing certain medical conditions. This biomarker potential opens up new avenues for precision medicine and personalized healthcare. d. Pharmaceutical Research and Drug Development: In the pharmaceutical research and development landscape, understanding the intricate role of Opiorphin is of paramount importance. IVD assays for Opiorphin contribute significantly to drug discovery and development efforts. These assays can aid in safety assessments, pharmacokinetic studies, and the evaluation of the therapeutic potential of new drug candidates targeting pain and mood disorders. In summary, the precise measurement of Opiorphin is of immense significance within the expansive field of in vitro diagnosis (IVD). It offers valuable insights into pain modulation, mood regulation, and potential biomarker applications. Our specialized product portfolio plays a pivotal role in enabling accurate and sensitive Opiorphin testing, contributing to advancements in pain management, mood-related research, and pharmaceutical development. As the field of IVD continues to advance and expand its horizons, our unwavering commitment to providing innovative solutions for Opiorphin measurement remains a driving force behind scientific understanding and patient care. The exploration of Opiorphin's multifaceted roles continues to offer promise for enhancing healthcare and advancing our knowledge of pain and mood regulation.

About GDU